Histopathological Spectrum of Benign Breast Lesions in Makurdi,North-Central Nigeria: A 10-Year Retrospective Study
Keywords:
Benign breast lesions, Fibroadenoma, Fibrocystic disease, HistopathologyAbstract
Benign breast lesions (BBLs) represent the majority of breast pathologies globally, yet their epidemiological profiles vary by region. In Sub-Saharan Africa, understanding these patterns is crucial for effective clinical management and allocation of resources. This study provides a 10-year update on the histopathological spectrum of BBLs in Makurdi, North-Central Nigeria. This was a retrospective, descriptive study utilising histopathology records of breast biopsies and excisions performed at the Federal Medical Centre, Makurdi, from January 1, 2014, to December 31, 2023. Data on patient age, sex, and definitive histological diagnosis of benign breast lesions were extracted and analysed using descriptive statistics. A total of 432 histologically confirmed benign breast lesions were identified. The majority (98%) occurred in females, with only 2% in males (predominantly gynaecomastia). Fibroadenoma was the most prevalent BBL, accounting for 337 cases (78.01%). Its mean age of occurrence was 23.4 years, with peak incidence in the 10-20 (148 cases) and 21-30 (121 cases) age groups. Fibrocystic disease was the second most common, with 46 cases (10.65%), having a mean age of 33.3 years. Other identified lesions included ductal ectasia (4.86%, n mean age 41.2 years) and various inflammatory lesions. Fibroadenoma remains the predominant benign breast lesion in Makurdi,
consistent with regional and global trends, primarily affecting young women. Fibrocystic disease is the second most common. These findings highlight the need for continued public health awareness and accurate diagnostic strategies to manage breast lumps in the region effectively.
References
1. Nardin S, Mora E, Folli S, Rossini C, Michelotti A, Liotto L, et al. Benign breast disease and breast cancer risk: Morphology and beyond. Breast. 2020; 54:235–243. doi: 10.1016/j.breast.2020.10.012.
2. Li CI, Malone KE, Tang MTC, Daling JR, Porter PL, Kerlikowske K, et al. Changes in benign breast disease diagnoses in a large integrated health care delivery system during the era of widespread mammography screening and menopausal hormone therapy decline. Cancer Epidemiol Biomarkers Prev. 2021;30(1):152–158. doi: 10.1158/1055-9965.EPI-20-0843.
3. Adesina A, Chukwuonye I, Adeyanju O, Omonisi A, Salako O, Abudu E, et al. The pattern of benign breast diseases in sub-Saharan Africa: A systematic review and meta-analysis. J Glob Oncol. 2021; 7:1–10. doi:10.1200/JGO.21.00058.
4. Uyisabye I, Biracyaza E, Bigirimana JB, Niyonzima E, Mukeshimana M, Uwineza A, et al. Spectrum of breast diseases in rural Rwanda: A cross-sectional study with review of literature on sub-Saharan Africa. BMC Women's Health. 2020;20(1):1–8. doi:10.1186/s12905-020-01113-3.
5. Abdulaziz MM, Uwimana MC, Nshimiyimana L, Hakizimana E, Uwizeye S, Bizimana T, et al. Pattern of breast lesions in a tertiary hospital in Rwanda: A five-year histopathological review. Rwanda Med J. 2022;79(3):3–8.
6. Olu-Eddo AN, Ohanaka CE. Benign breast lesions in an African population: A 25-year review. Niger J Clin Pract. 2018;21(12):1546-1551. doi: 10.4103/njcp.njcp_319_17
7. Adesunkanmi AR, Agbakwuru EA, Etonyeaku AC, Adeoye PO, Olabode OO, Salami KO, et al. Spectrum of breast diseases in Ile-Ife, Nigeria: A 15-year review. Niger J Surg. 2023;29(1):42–47. doi: 10.4103/njs.njs_38_22.
8. Mohammed A, Ahmed SA, Aji SA, Abdullahi MU, Yusuf HM, Sani A, et al. Histopathological pattern of breast lesions in Kano, North-Western Nigeria: A ten-year review. Ann Afr Med Res. 2021;4(1):45–50.
9. Mungadi IA, Agbo SP, Ismail NJ, Umaru A, Balarabe HM, Abdullahi M, et al. Pattern of benign breast diseases in Sokoto, North-Western Nigeria. Sub Saharan Afr J Med. 2020;7(1):27–31. doi: 10.4103/ssajm.ssajm_25_19.
10. Mandong BM, Orkar KS, Igun GO, Agbaji OO, Aboki CO, Emokpae AA, et al. Pattern of breast lesions in Jos, Nigeria: A review of 455 consecutive cases. Niger J Med. 2019;28(4):426–432. doi: 10.4103/NJM.NJM_59_19.
11. Eke B, Ojo BA, Okonkwo CE, Mba IN, Ngbea JA, Vhriterhire R. Benign breast diseases in Makurdi, North Central Nigeria: A retrospective review of One Hundred and Thirty-Five (135) Cases. Asian J of Med and Health. 2017;4 (2):1-6. doi:10.9734/AJMAH/2017/32367.
12. Adebamowo CA, Ayeni O, Awolude OA, Omodele RA, Salako BL, Oyesegun AR, et al. Benign breast disease at a tertiary hospital in Ibadan, Nigeria: A 10-year review. West Afr J Med. 2019;36(2):95-100.
13. AAbdulkareem FB, Daramola AO, Banjo AAF. Fibroadenoma of the breast in a Nigerian male: Case report and literature review. Niger Med J. 2017;58(1):31-33. Doi: 10.4103/nmj.NMJ_291_16.
14. Ayoade BA, Olaogun JG, Etonyeaku AC, Rahman GA, Ogundiran TO, Adeoti ML, et al. Male breast diseases in a tertiary hospital in Southwest Nigeria: A 20-year retrospective study. Pan Afr Med J. 2020; 36:193. doi:10.11604/pamj.2020.36.193.24295.
15. Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab. 2019;104(9):4321–4326. doi:10.1210/jc.2019-00537.
16. Adesunkanmi ARK, Agbakwuru EA, Odu OO, Fadiora FO, Aderounmu AO, Oyebamiji EO. Benign breast disease in African women: a 10-year experience at Ile-Ife. Niger Postgrad Med J. 2021;28(2):122–8.
17. Oluwole AO, Ayoade BA, Omoniyi-Esan GO, Alatise OI, Komolafe AO, Adeyemi BF, et al. Histopathological analysis of benign breast diseases in Lagos: A 10-year review. Afr J Med Med Sci. 2021;50(1):109–116.
18. Santen RJ, Mansel R. Benign Breast Disorders. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2023. PMID: 25905216.
19. Darvishian F, Singh K, Simsir A, Akkas G, Gomez-Fernandez C, Ginter PS, et al. Benign Breast Pathology. Surg Pathol Clin. 2022;15(1):1–20. doi: 10.1016/j.path.2021.11.001.
20. Adejumo PO, Irurhe NK, Olowoyeye OA, Adeyemi AS, Akinwunmi AO, Abayomi EA, et al. Barriers to breast cancer screening among older women in Nigeria: A single-centre study. J Glob Oncol. 2019; 5:1–6. doi:10.1200/JGO.19.00107.
21. Adesina A, Chumba D, Nelson AM, Orem J, Roberts DJ, Wabinga H, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol. 2013;14(4): e152–e157. doi:10.1016/S1470-2045(12)70598-3.
